Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement
Massimo DominiciLaboratory of Cell Biology and Advanced Cancer Therapy, Oncology-Hematology Department, University of Modena and Reggio Emilia, Modena, Italy. [email protected]Katarina Le BlancCenter for Allogeneic Stem Cell Transplantation, Department of Laboratory Medicine, Karolinska University Hospital, Karolinska Institute, Stockholm, SwedenIngo MuellerDepartment of Hematology and Oncology, University Children's Hospital, Tuebingen, GermanyIneke Slaper‐CortenbachDepartment of Medical Immunology, UMC Utrecht, Utrecht, the NetherlandsF. MariniDepartment of Blood and Marrow Transplant, UT-MD Anderson Cancer Center, Houston, TexasUSADiane S. KrauseDepartment of Laboratory Medicine, Yale University School of Medicine, Connecticut, New Haven, USAR. DeansAthersys Inc., Cleveland, OhioUSAArmand KeatingDepartment of Medical Oncology and Hematology Princess Margaret Hospital/Ontario Cancer Institute Toronto, Ontario, CanadaDarwin J. ProckopCenter for Gene Therapy, Tulane University Health Sciences Center, Louisiana, New Orleans, USAEdwin M. HorwitzDivisions of Stem Cell Transplantation and Experimental Hematology, St Jude Children's Research Hospital, Memphis TennesseeUSA
2006en
ABI
Аннотация
Аннотация отсутствует.
Идентификаторы
Цитирования и источники
Цитирований: 6Использованных источников: 0